“I think it’s really important that people keep signing up to these type of trials to push research forward.”
A trial looking at lenalidomide after chemotherapy for T cell lymphoma of the skin
This trial was looking at lenalidomide after treatment with chemotherapy for advanced T cell lymphoma of the skin.
Chemotherapy often shrinks or gets rid of the cancer but sadly it can start to grow again. Doctors are looking for treatments to help people in this situation. In this trial they were testing a drug called lenalidomide.
Lenalidomide is a type of biological therapy. It works mainly by helping the body’s
Doctors wanted to find out
- If having lenalidomide after chemotherapy could prevent or delay the cancer coming back
- More about the side effects
Summary of results
We have contacted the trial team who tell us that unfortunately they don’t expect to be making results available for this trial.
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sean Whittaker
European Organisation for Research and Treatment of Cancer (EORTC)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer